See Pepper Bio’s 20-slide pitch deck that got Merck to back an AI-powered biotech creating drugs for untreatable diseases
Pepper Bio landed $6.5 million in seed funding led by NFX. The startup wants to improve the drug-discovery process for pharma companies using AI. Pepper Bio is also developing treatments itself and expects to begin clinical trials next year. Drug discovery is expensive and time-consuming for pharmaceutical and biotech companies. From identifying the right biological targets implicated in a disease, to developing drugs that impact those targets through years-long clinical…